Immunotherapy for urothelial carcinoma: current evidence and future directions

A Tripathi, ER Plimack - Current urology reports, 2018 - Springer
Abstract Purpose of Review Until recently, effective treatment options for patients with
advanced urothelial carcinoma were limited to platinum-based chemotherapy. In the post …
被引用次数：60 相关文章

Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions.

A Tripathi, ER Plimack - Current Urology Reports, 2018 - europepmc.org
Until recently, effective treatment options for patients with advanced urothelial carcinoma
were limited to platinum-based chemotherapy. In the post-platinum setting and for patients …

Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions

A Tripathi, ER Plimack - Current urology reports, 2018 - pubmed.ncbi.nlm.nih.gov
Purpose of review Until recently, effective treatment options for patients with advanced
urothelial carcinoma were limited to platinum-based chemotherapy. In the post-platinum …

[引用][C] Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions

A Tripathi, ER Plimack - Current Urology Reports, 2018 - cir.nii.ac.jp
Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …